Summary - December 12. Another satisfactory status quo

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
210
Summary - December 12.

Another satisfactory status quo day.

Trades as per earlier update - 2.32M bought on bid and .77M bought on ask.

Only 87M has been picked up on the bid at .0003 in 16 weeks - 57M of it from insignificant paint downs in conjunction with associated bashing comments on iHub from the usual suspects - and 30M from the single nonsensical / suspicious transaction on Dec 5.

By comparison, 398M has been loaded at .0004 in the same period.

In the meantime $DIGX has no shortage of long-term GTC bidders at .0003 who will not be cancelling as the clueless might assume. The 4 main whales I recognise would - from my previous observations - normally be in for adding 25M > 30M at .0003. They probably already have 57M by my estimation (by deducting what I believe basher / flippers got). The bid was topped up again today by a further 3M shares.

The PR associated with the 2017 Q3 - that was filed on November 16 - has not been issued yet. The PR associated with 2016 Q3 came out on December 12, 2016 - see here:

http://www.otcmarkets.com/stock/DIGX/news/DIG...08&b=y

Until the PR comes out highlighting the excellent results - and hopefully also updating future brand expansion plans - only those who were looking for the Q3 - who mostly already have their shares - have seen it.

http://www.otcmarkets.com/stock/DIGX/news/DIG...08&b=y

The nonsense on iHub has been ramping up again from the 3 x bashers that appear to be operating in a conspiracy. There are now all Mods over there and are deleting posts that correct their nonsense. However, as the trading summary shows, there are not having much success in persuading any significant holder to sell for a loss into their waiting bids - and they are being outbid by better traders.

In due course, the Q4 results will speak for themselves and - when PR'ed to the wider investing community - we should see serious additional new interest due to the low O/S and relatively high positive revenue for a stock in this price range - just as happened for the 2016 Q4 and the 2017 Q1 and Q2. In addition, those reluctant to buy on the ask whilst they think they still have a chance of filling on the bid before the Q4 will probably change their mind in January - ask buying started on January 13 at the beginning of this year.

As always, anything could happen at anytime. So stay sharp if you don't already have all the shares you need to make your profit expectations up to Q4 in March 2018 and thereafter in 2018. Prior warning and / or scanner alerts of any significant buys when the PR comes out will not be given on iHub but they will be alerted here immediately.

Content below the line mainly unchanged from last update - relevant to those that are new here.

The long-term whales who trade $DIGX will continue to buy shares at any price that makes sense to them to use on multiple runs during the remainder of 2017 (there is usually a Q4 estimate + plans update in December) and throughout 2018. It is already known from posted comments and observation that at least 3 of the main whales are bidding for shares from the impatient at year end.

As previously stated, the large additional share retirement of 275M shares since Jul 31 - on top of the 150M retired Dec 2016 > May 2017 making 425M total - has not been PR'ed yet either.

Excellent update recently on the Verified Company Profile share structure at otcmarkets.com from the Transfer Agent (see new sticky #1902) - this has not been PR'ed yet to the wider investing community and has not been spotted by the inattentive on iHub:

O/S and A/S confirmed unchanged as at Nov 30, 2017.

Float same as for all the runs this year - 50M reduction since Dec 2016.

Another 275M shares retired between Jul 31 and Oct 31 (as promised).

That takes total retired to 425M since May 31 - a significant reduction on such a small A/S and O/S for a stock in this price range.

From observataion, it is known there are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 25M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q4. Shares bought at .0005 should easily return 100%+ at some point in 2018.

In my experience, 70M>100M (or 250M at year end for the next year) is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year highs will not require any shares bought above .0004 now so all others will be tradeable going forward.

As expected, the status quo has been pretty much maintained throughout the inter Q2/Q3 PR period with it making little difference to long-term traders whether shares are picked up at .0003/4/5/6 - they will see a profit on all of them by Q4 and on various runs between. The big boys in DIGX will probably be aiming to have an inventory of 50M>150M for trading through to end-2017 and into 2018 up to Q4.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan announced earlier - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 / year end PR and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>150M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

There have never been any promotion campaigns on $DIGX in the modern era on the current business model - since the acquisition of Expressions Chiropractic & Rehab in January 2016 and I don't think there will be any. The PRs alone + OTC market off-the-bottom specialists spotting the loading on scanners, keeping accurate records and networking with other traders has proved sufficient to generate multiple runs in 2017 and should do the same in future throughout 2018.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small). It remains the top earner in 2017.

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.





American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Accuray Finishes Key Deal, Resetting Financial Trajectory

Updated Category News Views 22

Accuray Secures the Deal, But Is the Future Bright? Every now and then in the investing world, a company pulls off a maneuver that you wish you’d thought of first. Today, folks, it's Accuray's turn. They've just wrapped up a monstrous transaction with TCW – their primary lender and shareholder – that has them feeling optimistic about the road ahead. Bold Moves to...

Continue Reading
Data Center Transformers on the Brink of a Boom

Updated Category News Views 235

A Flash Look: Powering Up Data Centers Look, if you're thinking of sidestepping data center transformers as just another cog in the machine, think again. This market's set to balloon—doubling from $5.59 billion in 2026 to a jaw-dropping $10.72 billion by 2031. We're talking a chunky 13.9% CAGR. Not every bit of news grabs you by the lapels, but this one does. What’s...

Continue Reading
FiEE Rockets to Profitability with 382% Revenue Surge

Updated Category News Views 56

Big Moves in the Tech Jungle: FiEE's Comeback Let's chew the fat on FiEE, Inc., a company that's left its hardware-heavy past in the dust and grabbed the bull by the horns with fresh, AI-driven brand tech solutions. We're talking a whopping 382.1% revenue increase. Now, that's not chump change. From barely scraping $2 million last year to raking in $9.6 million just for...

Continue Reading
Custom Upholstered Furniture: Comfort Built to Last

Updated Category News Views 43

Rethinking Furniture Comfort: Not Just a Luxury Diving into the world of custom upholstered furniture with insights from Randy Marohn is like finding a cheat sheet for comfort. Seriously, it ain't just about plush cushions or slick fabrics—it's a bonafide science. Marohn, from Sans Furniture Inc. in good ol’ Hamburg, NY, unfolds a tale of intentional design and...

Continue Reading
Noël Jolié's Cream Earns Spot on Oprah's List

Updated Category News Views 33

The Powerhouse of Oprah's Seal of Approval Ever notice what happens when Oprah drops a nod towards any brand? It's like Midas touching everything gold. That's exactly the scenario with Noël Jolié, a Chicago-based luxury body care operation, hitting the jackpot by landing its Velours Silken Body Cream on Oprah's Favorite Things 2026. You can't buy this kind of press,...

Continue Reading
Fitness Career Platform's Big Ramp Up Sparks Buzz

Updated Category News Views 73

ISSA Career Connect Gains Industry Recognition In a world where finding that first job post-certification can be as brutal as a spin class in August, ISSA Career Connect seems to be offering a bit of a lifeline. This platform, already making some serious noise in the fitness industry, has just snagged a place as a finalist for App of the Year at the 2026 Beyond Activ...

Continue Reading
Aluminum Fluoride Market to Hit $3.3B by 2031

Updated Category News Views 80

Eye on the Aluminum Fluoride Surge Cracking open the numbers, the aluminum fluoride market is projected to swell from $2.48 billion in 2026 to a hefty $3.30 billion by 2031, trucking along at a CAGR of 5.9%. That's no small potatoes in the world of industrial materials. Scratch the surface, and you’ll see what's fueling this climb—think of it as a bellwether for...

Continue Reading
Odessa Water Overbilling Lawsuit Surges Ahead

Updated Category News Views 106

Full Steam Ahead for Odessa's Water Fight Odessa, a dust-blown Texas town, ain't giving up without a fight. The court just lit a fire under the efforts of 46,000 residents and businesses hollering about their water bills that seemed to skyrocket outta nowhere. This court ruling lets the class action against the City of Odessa and Performance Services—they're the folks...

Continue Reading
Kentucky Power's Bold Plan to Boost Local Economy

Updated Category News Views 57

Electricity, Economy, and Execution Kentucky Power just laid out plans that could massively swing the pendulum for eastern Kentucky's economic prospects. They've put filings on the table for the Kentucky Public Service Commission that, if approved, promise big economic benefits. We're talking about a potential infusion of $500 million through fixed-rate offsets and an...

Continue Reading
Dana-Farber Integrates IconPCR for Precise cfDNA Sequencing

Updated Category News Views 52

Innovating Precision in cfDNA Sequencing One day you're trudging along old paths, and the next, technology throws you a curveball that's too critical to ignore. That's the scene at Dana-Farber Cancer Institute with their latest lab upgrade. They've bent the knee to integrate n6's iconPCR system into their toolkit for liquid biopsy research—a move that's caught my...

Continue Reading

Top 5 Most Recently Viewed Articles

GlycoMimetics Faces Challenges Amid 52-Week Low and Restructuring

Updated Category News Views 128

GlycoMimetics Stock Hits Troubling Low GlycoMimetics Inc. (NASDAQ: GLYC) has seen its stock fall to a concerning 52-week low of just $0.14. This steep decline of -88.71% over the past year has raised alarm among investors. The biotechnology company, known for its focus on glycomimetics, is currently facing significant scrutiny as it works through these troubling times....

Continue Reading
Medicenna Showcases Innovative Immunotherapy Developments

Updated Category News Views 108

Advancements in Cancer Treatment by Medicenna Medicenna Therapeutics is making significant strides in immunotherapy with its groundbreaking MDNA113 and MDNA11 programs. MDNA113, a tumor-targeted and ‘masked’ BiSKIT (Bifunctional SuperKine for ImmunoTherapy), is engineered to deliver anti-PD1-IL-2 Superkine specifically to the tumor microenvironment (TME). This...

Continue Reading
Viking Therapeutics Showcases VK2735 Obesity Research at Conference

Updated Category News Views 212

Viking Therapeutics Shares Insights on VK2735 Obesity Program Viking Therapeutics, Inc. (NASDAQ: VKTX), a biopharmaceutical company dedicated to innovative treatments for metabolic and endocrine disorders, is excited to announce presentations at two prestigious events in 2025. The company's VK2735 program is poised to take center stage at ObesityWeek 2025, occurring from...

Continue Reading
ERMProtect Partners with NimbusDDOS for Robust DDoS Testing

Updated Category News Views 31

ERMProtect Expands Its Cybersecurity Arsenal A cybersecurity firm that knows its stuff, ERMProtect, has teamed up with NimbusDDOS, the big dog in DDoS preparedness. Why does this matter, you ask? Because keeping your systems online amidst a digital pummeling isn’t just smart business—it's become a regulatory headache. Understanding the Need for DDoS Resilience Nobody...

Continue Reading
Cavago and ShaikhTech Join Forces to Transform the Equine Sector

Updated Category News Views 261

Partnership Revolutionizes the Equestrian World In a groundbreaking move, ShaikhTech and Cavago are joining forces to advance digital technology in the equine industry. Their partnership promises to bring transformative 3D digital experiences to equestrians and horse enthusiasts worldwide. The Mission of Cavago Cavago is dedicated to modernizing the equestrian experience...

Continue Reading